Emalex Biosciences logo
VerifiedBiotechnology Research· Founded 2018

Emalex Biosciences

Emalex Biosciences is in late-stage development for a new class of drug for patients with Tourette syndrome and other neurological disorders.

7-day free trial · no credit card

HeadquartersChicago, United StatesEmployees50(11 to 50)Annual revenue$1M to <$10MFounded year2018Websiteemalexbiosciences.comLinkedIn profileLinkedIn

Verified contacts

35

available on Kipplo

LinkedIn employees

50

11 to 50 range

Open roles

no listings

Distinct roles

24

indexed titles

Tech stack

5

tools in use

Monthly traffic

160

organic / mo

Sign up free to see all 35 verified contacts at Emalex Biosciences

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

35 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Emalex Biosciences

24 distinct titles indexed · top 10 shown.

  • 2commercial consultant and business analytics
  • 2vice president, market access and patient services
  • 1()
  • 1,,
  • 1assistant controller
  • 1associate director medical affairs operations
  • 1avp quality assurance
  • 1chief executive officer
  • 1corporate controller
  • 1director of clinical supply chain
  • +14more titles

Sign up to unlock all 35 contacts at Emalex Biosciences

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 35 verified contacts at Emalex Biosciences

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Emalex Biosciences | Kipplo Discover